The primary purpose of this study is to examine the effects of regular exergaming for 8 weeks in 24 overweight/obese children and adolescents (10-17 years) on maximal aerobic fitness (VO2max) and physical activity levels measured before and after (8 weeks) intervention period, and in addition at follow-up (12 weeks). We also wish to investigate the effects on markers of cardio metabolic health and body composition, measured at baseline, 8 weeks and 12 weeks follow-up. Also, the participants gaming frequency will be registered throughout the 8 week period, as well as during the follow-up between 8 and 12 weeks. Aim of this study is to investigate if access to this game can provide health benefits for overweight/obese children and adolescents.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
6
The participants in the Exergaming group will use the PlayPulse exergame for 45 minutes a minimum of three times per week for 8 weeks. Between 8 and 12 weeks the exergaming group will be provided with free access to the exergame but without the two mandatory exergaming sessions
Department of Circulation and Medical Imaging
Trondheim, Norway
Daily time physical activity (moderate, vigorous and very vigorous)
Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and at 12 weeks.
Time frame: 12 weeks
Daily average energy expenditure
Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 8 weeks and 12 weeks.
Time frame: 8 and 12 weeks
Daily average number of steps
Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 8 weeks and 12 weeks.
Time frame: 8 and 12 weeks
Daily time in sedentary activity (< 3.0 metabolic equivalents = METs)
Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 8 weeks and 12 weeks.
Time frame: 8 and 12 weeks
Daily time in moderate intensity activity (3.0-6.0 metabolic equivalents = METs)
Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 8 weeks and 12 weeks.
Time frame: 8 and 12 weeks
Daily time in vigorous intensity activity
Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 8 weeks and 12 weeks.
Time frame: 8 and 12 weeks
Daily time in very vigorous intensity activity (>9.0 metabolic equivalents = METs)
Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 8 weeks and 12 weeks.
Time frame: 8 and 12 weeks
Daily average total physical activity duration
Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 8 weeks and 12 weeks.
Time frame: 8 and 12 weeks
Bioelectrical impedance
Body composition assessed using bioelectrical impedance analysis (InBody 720)
Time frame: 8 and 12 weeks
Blood Pressure
Time frame: 8 and 12 weeks
Fasting circulating glucose, as blood marker of cardiometabolic health
Time frame: 8 and 12 weeks
Fasting triglycerides, LDL-, HDL- and Total cholesterol, as blood marker of cardiometabolic health
Time frame: 8 and 12 weeks
Circulating insulin concentration, as blood marker of cardiometabolic health
Time frame: 8 and 12 weeks
glucose response to a 2 hour glucose tolerance test, as blood marker of cardiometabolic health
Time frame: 8 and 12 weeks
VO2max
Maximal Aerobic Capacity
Time frame: 8 and 12 weeks
Daily time physical activity (moderate, vigorous and very vigorous)
Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and at 8 weeks
Time frame: 8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.